Categories Earnings, Health Care
Earnings Summary: CooperCompanies (COO) reports Q2 2023 financial results
Medical device maker CooperCompanies (NYSE: COO) has announced financial results for the second quarter of 2023, reporting lower earnings despite an increase in revenues.
- Second-quarter revenue rose 6% year-over-year to $877.4 million; CooperVision revenue rose 6% and CooperSurgical revenue moved up 4%
- Net earnings per share, including special items, came in at $0.80, down 69% from last year’s earnings of $2.55
- Net income was $39.8 million in the April quarter, compared to $126.6 million in Q2 2022
- Adjusted earnings decreased to $3.08 per share in Q2 from $3.24 per share in the same period of last year
- The operating margin was 11%, lower than the 16% margin reported a year earlier
- Cash provided by operations totaled $124.2 million and free cash flow came in at $50.6 million
Most Popular
United Airlines (UAL) Earnings: 4Q24 Key Numbers
United Airlines (NASDAQ: UAL) reported total operating revenue of $14.7 billion for the fourth quarter of 2024, up 7.8% compared to the same period last year. Net income increased 64%
Highlights of Abbott Laboratories (ABT) Q4 2024 results
Abbott Laboratories (NYSE: ABT) on Wednesday announced financial results for the fourth quarter of 2024, reporting an increase in sales and adjusted profit. Total reported sales increased 7.2% year-over-year to
PG Earnings: Key quarterly highlights from Procter & Gamble’s Q2 2025 financial results
The Procter & Gamble Company (NYSE: PG) reported its second quarter 2025 earnings results today. Net sales were $21.9 billion, up 2% from the prior-year quarter. Organic sales increased 3%.